CIK 0001590750 · Large accelerated filer
Viridian Therapeutics, Inc.\DE
Sign in to watch- Ticker
- VRDN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471187261
- Phone
- 617.272.4600
- Business address
- 221 CRESCENT STREET, SUITE 103A, WALTHAM, MA, 02453
- Former names
- MIRAGEN THERAPEUTICS, INC., SIGNAL GENETICS, INC., SIGNAL GENETICS LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $348,194
- in 1 filing
Net −$348,194. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 15 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-02-13 | Marshall William Stuart President & CEO | Option exercise · Stock Option (right to buy) | −115,818 | 0 | ||
| 2018-02-13 | Levy Adam Scott Chief Business Officer | Purchase | +9,090 | $5.50 | $50K | 10,540 |
| 2018-02-13 | Booth Bruce Director | Purchase | +545,454 | $5.50 | $3.0M | 1,351,090 |
| 2018-01-31 | Leverone Jason A. CFO, Treasurer & Secretary | Grant or award · Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2018-01-31 | Levy Adam Scott Chief Business Officer | Grant or award · Stock Option (right to buy) | +80,000 | 80,000 | ||
| 2018-01-31 | RUBIN PAUL D EVP, Research & Development | Grant or award · Stock Option (right to buy) | +85,000 | 85,000 | ||
| 2018-01-31 | Marshall William Stuart President & CEO | Grant or award · Stock Option (right to buy) | +245,000 | 245,000 | ||
| 2018-01-03 | Hughes Thomas E. Director | Grant or award · Stock Option (right to buy) | +3,426 | 3,426 | ||
| 2018-01-03 | Booth Bruce Director | Grant or award · Stock Option (right to buy) | +10,191 | 10,191 | ||
| 2017-12-20 | Hughes Thomas E. Director | Sale | −12,000 | $8.00 | $96K | 2,827 |
| 2017-06-28 | LEFKOFF KYLE Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2017-06-28 | KOCH KEVIN Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2017-06-28 | TURNER JOSEPH L Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2017-06-28 | Creecy John W Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2017-06-28 | Hughes Thomas E. Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2017-06-28 | Booth Bruce Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2017-06-22 | Levy Adam Scott Chief Business Officer | Purchase | +200 | $7.55 | $2K | 200 |
| 2017-03-24 | Booth Bruce Director | Grant or award · Stock Option (right to buy) | +6,844 | 6,844 | ||
| 2017-03-24 | Hughes Thomas E. Director | Grant or award | +778 | 14,840 | ||
| 2017-03-24 | Hughes Thomas E. Director | Grant or award · Stock Option (right to buy) | +1,191 | 1,191 |
Page 13 of 16 · 309 trades